Financials
- Market Capitalization 32.62 M
- Employee 4
- Founded 2006
- CEO N/A
- Website www.briacell.com
- Headquarter British Columbia, Canada
- FIGI BBG0018783B6
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4452 | LSTA Lisata Therapeutics, Inc. - Common Stock | 3.70 USD | +13.15% | +11.11% | +5.11% | +42.86% | 33.69 M USD | ||
| 4459 | GOSS Gossamer Bio, Inc. - Common Stock | 0.14 USD | -17.65% | -26.32% | -17.65% | -90.91% | 32.86 M USD | ||
| 4464 | LITS Lite Strategy, Inc. - Common Stock | 0.95 USD | -5.94% | -3.06% | +21.79% | -68.12% | 32.32 M USD | ||
| 4474 | SER Serina Therapeutics, Inc. Common Stock | 2.09 USD | 0.00% | +6.09% | +8.85% | +25.53% | 31.34 M USD |
Frequently asked questions about BriaCell Therapeutics Corp. - Common Shares
What is the BriaCell Therapeutics Corp. - Common Shares stock price today?
The current price of BriaCell Therapeutics Corp. - Common Shares (BCTX) is 3.75. Over the past 24 hours, the stock has changed by -4.82%. Follow the BCTX chart for real-time price dynamics.
What is the stock ticker of BriaCell Therapeutics Corp. - Common Shares?
BriaCell Therapeutics Corp. - Common Shares trades under the ticker BCTX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is BriaCell Therapeutics Corp. - Common Shares stock going up?
BCTX has changed by +5.04% over the last week, +31.12% over the last month, and +89.39% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was BriaCell Therapeutics Corp. - Common Shares net income for the last quarter?
BriaCell Therapeutics Corp. - Common Shares reported net income of -7.16 M for the last quarter. The previous quarter showed -7.22 M, which means net income changed by +0.79%.
How many employees does BriaCell Therapeutics Corp. - Common Shares have?
As of the latest available data, BriaCell Therapeutics Corp. - Common Shares has 4 employees. Workforce size can provide additional context about the company's scale and operations.
What is BriaCell Therapeutics Corp. - Common Shares EBITDA?
BriaCell Therapeutics Corp. - Common Shares EBITDA is -7.59 M, and its EBITDA margin is 289.82 K%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy BriaCell Therapeutics Corp. - Common Shares stock?
You can buy BriaCell Therapeutics Corp. - Common Shares (BCTX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in BriaCell Therapeutics Corp. - Common Shares stock?
Investing in BriaCell Therapeutics Corp. - Common Shares requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the BCTX chart and related analysis on metatrader.com as part of your research.